Dr. Hussein Tawbi on Efficacy and Safety Results From the CheckMate 204 Melanoma Trial

June 19, 2019
Hussein Abdul-Hassan Tawbi, MD, PhD
Hussein Abdul-Hassan Tawbi, MD, PhD

Cancer Network spoke with Hussein Tawbi, MD, PhD, of MD Anderson Cancer Center, about the efficacy and safety of the combination of nivolumab plus ipilimumab in patients with symptomatic melanoma brain metastases.

Cancer Network spoke with Hussein Tawbi, MD, PhD, of MD Anderson Cancer Center, about the efficacy and safety of the combination of nivolumab plus ipilimumb in patients with symptomatic melanoma brain metastases.